BerandaBHC • NYSE
add
Bausch Health Companies Inc
$7,32
Setelah Jam Perdagangan Normal:(0,15%)+0,011
$7,33
Tutup: 15 Jul, 17.53.51 GMT-4 · USD · NYSE · Pernyataan Penyangkalan
Tutup sebelumnya
$7,42
Rentang hari
$7,26 - $7,42
Rentang tahun
$6,05 - $11,46
Kapitalisasi pasar
2,64 M USD
Volume Rata-Rata
2,45 jt
Rasio P/E
-
Hasil dividen
-
Berita pasar
Keuangan
Laporan Pendapatan
Pendapatan
Laba bersih
(USD) | Mar 2024info | Perubahan Y/Y |
---|---|---|
Pendapatan | 2,15 M | 10,75% |
Biaya operasional | 1,21 M | 6,96% |
Laba bersih | -64,00 jt | 68,16% |
Margin laba bersih | -2,97 | 71,28% |
Penghasilan per saham | 0,59 | 11,72% |
EBITDA | 619,00 jt | 13,37% |
Tarif pajak efektif | -11,59% | — |
Neraca
Total aset
Total liabilitas
(USD) | Mar 2024info | Perubahan Y/Y |
---|---|---|
Investasi tunai jangka pdk | 733,00 jt | 41,51% |
Total aset | 26,91 M | 5,77% |
Total liabilitas | 27,09 M | 7,06% |
Total ekuitas | -174,00 jt | — |
Saham yang beredar | 366,80 jt | — |
Harga terhadap reservasi | -2,44 | — |
Tingkat pengembalian aset | 2,75% | — |
Pengembalian modal | 3,37% | — |
Arus Kas
Perubahan bersih tunai
(USD) | Mar 2024info | Perubahan Y/Y |
---|---|---|
Laba bersih | -64,00 jt | 68,16% |
Kas dari operasi | 211,00 jt | 37,01% |
Tunai dari investasi | -73,00 jt | 6,41% |
Tunai dari pembiayaan | -340,00 jt | -139,44% |
Perubahan bersih tunai | -207,00 jt | -245,00% |
Arus kas bebas | 311,00 jt | 23,41% |
Tentang
Bausch Health Companies Inc. is an American-Canadian multinational specialty pharmaceutical company based in Laval, Quebec, Canada. It develops, manufactures and markets pharmaceutical products and branded generic drugs, primarily for skin diseases, gastrointestinal disorders, eye health and neurology. Bausch Health owns Bausch & Lomb, a supplier of eye health products. Bausch Health's business model is primarily focused on acquiring small pharmaceutical companies and then sharply increasing the prices of the drugs these companies sell.
Valeant was originally founded in 1959, as ICN Pharmaceuticals by Milan Panić in California. During the 2010s, Valeant adopted a strategy of buying up other pharmaceutical companies which manufactured effective medications for a variety of medical problems, and then increasing the price of those medications. As a result, the company grew rapidly and in 2015 was the most valuable company in Canada.
Valeant was involved in a number of controversies surrounding drug price hikes and the use of a specialty pharmacy for the distribution of its drugs. This led to an investigation by the U.S. Wikipedia
CEO
Didirikan
1959
Kantor pusat
Situs
Karyawan
20.270